Doyon William M, Howard Elaina C, Shippenberg Toni S, Gonzales Rueben A
Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA.
Neuropharmacology. 2006 Sep;51(3):487-96. doi: 10.1016/j.neuropharm.2006.04.005. Epub 2006 Jun 15.
Our study examined ethanol self-administration and accumbal dopamine concentration during kappa-opioid receptor (KOPr) blockade. Long-Evans rats were trained to respond for 20 min of access to 10% ethanol (with sucrose) over 7 days. Rats were injected s.c. with the long-acting KOPr antagonist, nor-binaltorphimine (NOR-BNI; 0 or 20 mg/kg) 15-20 h prior to testing. Microdialysis revealed a transient elevation in dopamine concentration within 5 min of ethanol access in controls. NOR-BNI-treated rats did not exhibit this response, but showed a latent increase in dopamine concentration at the end of the access period. The rise in dopamine levels correlated positively with dialysate ethanol concentration but not in controls. NOR-BNI did not alter dopamine levels in rats self-administering 10% sucrose. The transient dopamine response during ethanol acquisition in controls is consistent with previous results that were attributed to ethanol stimulus cues. The altered dopamine response to NOR-BNI during ethanol drinking suggests that KOPr blockade temporarily uncovered a pharmacological stimulation of dopamine release by ethanol. Despite these neurochemical changes, NOR-BNI did not alter operant responding or ethanol intake, suggesting that the KOPr is not involved in ethanol-reinforced behavior under the limited conditions we studied.
我们的研究检测了κ-阿片受体(KOPr)阻断期间的乙醇自我给药及伏隔核多巴胺浓度。对Long-Evans大鼠进行为期7天的训练,使其能在20分钟内获取10%乙醇(加蔗糖)。在测试前15 - 20小时,给大鼠皮下注射长效KOPr拮抗剂诺-纳洛酮啡(NOR-BNI;0或20毫克/千克)。微透析显示,对照组在获取乙醇后5分钟内多巴胺浓度短暂升高。接受NOR-BNI治疗的大鼠未出现这种反应,但在获取期结束时多巴胺浓度出现潜在升高。多巴胺水平的升高与透析液乙醇浓度呈正相关,但在对照组中并非如此。NOR-BNI未改变自我给药10%蔗糖的大鼠的多巴胺水平。对照组在获取乙醇期间的短暂多巴胺反应与先前归因于乙醇刺激线索的结果一致。乙醇饮用期间对NOR-BNI的多巴胺反应改变表明,KOPr阻断暂时揭示了乙醇对多巴胺释放的药理学刺激作用。尽管有这些神经化学变化,但NOR-BNI并未改变操作性反应或乙醇摄入量,这表明在我们所研究的有限条件下,KOPr不参与乙醇强化行为。